Electrocardiographic Left Ventricular Hypertrophy as a Predictor for Nonsignificant Coronary Artery Disease in
Naoki Misumida1, Akihiro Kobayashi2, Madeeha Saeed3
1Department of Internal Medicine, Mount Sinai Beth Israel, New York, NY, USA nmisumida@chpnet.org.
Insights
Electrocardiographic left ventricular hypertrophy (LVH) predicts less severe coronary artery disease (CAD) in patients experiencing non-ST-segment elevation myocardial infarction (NSTEMI). This finding suggests LVH may indicate a lower need for immediate revascularization procedures.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Internal Medicine
Background:
- Left ventricular hypertrophy (LVH) can compromise coronary blood flow, leading to myocardial ischemia.
- Understanding predictors of coronary artery disease (CAD) severity in non-ST-segment elevation myocardial infarction (NSTEMI) is crucial for patient management.
Purpose of the Study:
- To investigate whether electrocardiographic LVH predicts nonsignificant CAD in patients with NSTEMI.
- To assess the association between LVH and in-hospital revascularization rates.
Main Methods:
- Retrospective analysis of 406 NSTEMI patients undergoing coronary angiography.
- LVH diagnosed using Sokolow-Lyon and Cornell voltage criteria.
- Nonsignificant CAD defined by specific coronary stenosis thresholds.
Main Results:
- 25% of patients had electrocardiographic LVH; 24% had nonsignificant CAD.
- LVH was associated with a higher prevalence of nonsignificant CAD (32% vs. 22%, P=.04).
- Patients with LVH showed lower in-hospital revascularization rates (45% vs. 69%, P<.001).
Conclusions:
- Electrocardiographic LVH is an independent predictor of nonsignificant CAD in NSTEMI patients.
- LVH is linked to reduced rates of in-hospital revascularization in this population.
Abstract:
Left ventricular hypertrophy (LVH) can lead to subendocardial ischemia by altering the coronary blood flow and its transmural myocardial distribution in the setting of increased oxygen demand. We hypothesized that electrocardiographic LVH predicts nonsignificant coronary artery disease (CAD) in patients with non-ST-segment elevation myocardial infarction (NSTEMI). We performed a retrospective analysis of 406 consecutive patients with NSTEMI who underwent coronary angiography. The LVH was diagnosed using Sokolow-Lyon and Cornell voltage criteria. Nonsignificant CAD was defined as stenosis less than 50% in the left main and 70% in any other coronary arteries. Of the 406 patients, 100 (25%) patients had electrocardiographic LVH and 99 (24%) patients had nonsignificant CAD. Patients with electrocardiographic LVH had a higher prevalence of nonsignificant CAD (32% vs 22%, P = .04) and a lower rate of in-hospital revascularization (45% vs 69%, P < .001) than those without LVH. On multivariate analysis, electrocardiographic LVH was an independent predictor of nonsignificant CAD (odds ratio 1.94; 95% confidence interval 1.12-3.35; P = .02). In conclusion, electrocardiographic LVH is an independent predictor of nonsignificant CAD and associated with a lower rate of in-hospital revascularization in patients with NSTEMI.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Acute Coronary Syndrome III: Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Hypertension III: Clinical Manifestations and Diagnostic Studies


